EXAS
Exact Sciences Corp
Price:  
46.36 
USD
Volume:  
2,372,503.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EXAS EV/EBITDA

-87.8%
Upside

As of 2024-07-15, the EV/EBITDA ratio of Exact Sciences Corp (EXAS) is 166.20. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. EXAS's latest enterprise value is 10,592.44 mil USD. EXAS's TTM EBITDA according to its financial statements is 63.74 mil USD. Dividing these 2 quantities gives us the above EXAS EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 25.0x - 31.8x 28.3x
Forward P/E multiples 39.2x - 43.6x 42.7x
Fair Price (2.40) - 13.14 5.68
Upside -105.2% - -71.6% -87.8%
46.36 USD
Stock Price
5.68 USD
Fair Price

EXAS EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-07-12 166.20
2024-07-11 161.79
2024-07-10 163.21
2024-07-09 159.62
2024-07-08 162.81
2024-07-05 161.01
2024-07-03 157.02
2024-07-02 156.96
2024-07-01 154.82
2024-06-28 154.30
2024-06-27 160.78
2024-06-26 159.83
2024-06-25 151.75
2024-06-24 153.43
2024-06-21 161.82
2024-06-20 159.36
2024-06-18 153.34
2024-06-17 151.63
2024-06-14 153.22
2024-06-13 155.74
2024-06-12 153.98
2024-06-11 153.98
2024-06-10 156.15
2024-06-07 156.26
2024-06-06 161.30
2024-06-05 163.85
2024-06-04 157.77
2024-06-03 161.74
2024-05-31 163.56
2024-05-30 162.98
2024-05-29 161.74
2024-05-28 168.11
2024-05-24 176.27
2024-05-23 188.55
2024-05-22 186.84
2024-05-21 186.93
2024-05-20 179.63
2024-05-17 177.83
2024-05-16 182.38
2024-05-15 186.40
2024-05-14 188.31
2024-05-13 192.92
2024-05-10 186.90
2024-05-09 188.75
2024-05-08 204.18
2024-05-07 209.77
2024-05-06 215.39
2024-05-03 211.68
2024-05-02 207.25
2024-05-01 205.72